Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Vaxcyte Inc (NASDAQ: PCVX) closed at $31.16 in the last session, down -0.92% from day before closing price of $31.45. In other words, the price has decreased by -$0.92 from its previous closing price. On the day, 2.03 million shares were traded.
Ratios:
We take a closer look at PCVX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 17.70 and its Current Ratio is at 17.70. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
On December 20, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $135.
On December 07, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $69.Mizuho initiated its Buy rating on December 07, 2023, with a $69 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 05 ’25 when Eydelman Mikhail sold 5,000 shares for $70.74 per share. The transaction valued at 353,699 led to the insider holds 41,620 shares of the business.
Eydelman Mikhail bought 5,000 shares of PCVX for $344,350 on Mar 05 ’25. On Mar 03 ’25, another insider, Wassil Jim, who serves as the CHIEF OPERATING OFFICER of the company, sold 8,000 shares for $73.27 each. As a result, the insider received 586,165 and left with 154,931 shares of the company.
Stock Price History:
Over the past 52 weeks, PCVX has reached a high of $121.06, while it has fallen to a 52-week low of $27.66. The 50-Day Moving Average of the stock is -36.58%, while the 200-Day Moving Average is calculated to be -62.28%.
Shares Statistics:
A total of 128.94M shares are outstanding, with a floating share count of 125.24M. Insiders hold about 2.92% of the company’s shares, while institutions hold 108.80% stake in the company.
